4. Drivers and Challenges
4.1 Drivers
4.1.1 Increased Awareness Due to Government Initiatives
4.1.2 Rising Chromosomal Abnormalities in Infants
4.1.3 Funding Aiding the Growth of Newborn Screening
4.2 Challenges
4.2.1 Lack of Hospital Infrastructure Proving Dangerous for Newborns
4.2.2 Unclear Regulatory Policies
5. US Newborn Screening Market Overview
6. Market Segmentation by Technology
6.1 Introduction
6.1.1 Enzymes and Immunoassays
6.1.2 Hearing Screening
6.1.3 Tandem Mass Spectrometry
6.1.4 Pulse Oximetry
6.1.5 DNA Based Assays
6.1.6 Electrophoresis
7. Trends and Developments
7.1 Newborn Screening Test Recommended for Pompe’s Disease
7.2 Next Generation Sequencing Foraying into Newborn Screening
8. Competitive Assessment
8.1 Perkin Elmer
8.2 Waters Corporation
8.3 Natus Medical
8.4 Agilent Technologies Inc.